Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherHot Topics (Invitation Only)

The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?

Alessio Imperiale, Abhishek Jha, Leah Meuter, Guillaume P Nicolas, David Taïeb and Karel Pacak
Journal of Nuclear Medicine February 2023, jnumed.123.265406; DOI: https://doi.org/10.2967/jnumed.123.265406
Alessio Imperiale
1 Nuclear Medicine and Molecular Imaging, ICANS, Strasbourg University, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhishek Jha
2 Eunice Kennedy Shriver NICHD, National Institutes of Health, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leah Meuter
2 Eunice Kennedy Shriver NICHD, National Institutes of Health, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume P Nicolas
3 Div. of Nuclear Medicine, Center for Neuroendocrine and Endocrine Tumors, University Hospital Basel, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Taïeb
4 La Timone University Hospital, CERIMED, Aix-Marseille University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karel Pacak
2 Eunice Kennedy Shriver NICHD, National Institutes of Health, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (3)
Journal of Nuclear Medicine
Vol. 64, Issue 3
March 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?
Alessio Imperiale, Abhishek Jha, Leah Meuter, Guillaume P Nicolas, David Taïeb, Karel Pacak
Journal of Nuclear Medicine Feb 2023, jnumed.123.265406; DOI: 10.2967/jnumed.123.265406

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?
Alessio Imperiale, Abhishek Jha, Leah Meuter, Guillaume P Nicolas, David Taïeb, Karel Pacak
Journal of Nuclear Medicine Feb 2023, jnumed.123.265406; DOI: 10.2967/jnumed.123.265406
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Hot Topics (Invitation Only)

  • The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors
  • Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging
Show more Hot Topics (Invitation Only)

Clinical (Oncology: Endocrine/Neuroendocrine)

  • Efficacy and safety of 124I-mIBG dosimetry-guided high activity 131I-mIBG therapy of advanced pheochromocytoma or neuroblastoma
  • Preliminary clinical experience of cholecystokinin-2 receptor PET/CT imaging using the 68Ga-labeled minigastrin analog DOTA-MGS5 in patients with medullary thyroid cancer
Show more Clinical (Oncology: Endocrine/Neuroendocrine)

Similar Articles

Keywords

  • Gastrointestinal
  • molecular imaging
  • Neuroendocrine
  • Oncology: GI
  • Peptides
  • PET/CT
  • radionuclide therapy
  • radiopharmaceuticals
  • Somatostatin
  • agonist
  • antagonist
  • neuroendocrine tumors
  • Theranostics
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire